Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

计划入组 200 人 · 首次发布于 2026 年 7 月 20 日

Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study

计划入组 72 人 · 首次发布于 2026 年 7 月 31 日

Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada

计划入组 6,000 人 · 首次发布于 2013 年 12 月 12 日

Canada Association

Cancer vaccine(CanTech Canada)

Quadrivalent inactivated influenza vaccine (Fluart Innovative Vaccines)

WORLDWIDE INNOVATIVE NETWORK

France

Innovative Molecules GmbH

Germany

Blueprint Medicines

United States

Orion Corporation Appoints Berkeley Vincent as Executive Vice President of Innovative Medicines

Health Canada Proposes Streamlined Drug Approvals Through Foreign Regulatory Partnerships

Canada's Pharma Task Force Urges Three-Month Deadline to Cut Drug Access Delays and Pricing Barriers